Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts

• Published in: The Journal of thoracic and cardiovascular surgery Vol. 94; no. 1; pp. 2 - 11
• Main Authors: Jett, GK, Arcidi, JM, Jr, Dorsey, LM, Hatcher, CR, Jr, Guyton, RA
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA AATS/WTSA 01.07.1987; Elsevier
• Subjects: Animals; Biological and medical sciences; Cardiovascular system; Dogs; Epinephrine - pharmacology; Ferricyanides - pharmacology; Mammary Arteries - transplantation; Medical sciences; Miscellaneous; Myocardial Revascularization; Nitroglycerin - pharmacology; Nitroprusside - pharmacology; Norepinephrine - pharmacology; Pharmacology. Drug treatments; Phenylephrine - pharmacology; Regional Blood Flow - drug effects; Saphenous Vein - transplantation; Thoracic Arteries - transplantation; Vascular Patency - drug effects; Fissipedia; Carnivora; Vasopressor agent; Smooth muscle; Blood flow; Vertebrata; Mammalia; Saphenous vein; Animal; Surgery; Blood vessel; Myocardium; Graft; Internal mammary artery; Hemodynamics; Dog; Revascularization
• ISSN: 0022-5223; 1097-685X
• DOI: 10.1016/s0022-5223(19)36312-3

The internal mammary artery is a dynamic coronary graft, whereas the saphenous vein graft is passive. Therefore, potential exists not only for beneficial vasodilation but also for catastrophic spasm of the artery. The purpose of this study was to examine blood flow in the internal mammary and saphenous vein grafts during infusion of drugs that are commonly used after cardiac operations. A canine right heart bypass preparation allowed precise control of cardiac output, blood pressure, and heart rate, which were maintained constant during drug infusion. Both the internal mammary and saphenous vein grafts were constructed so that they perfused the same coronary bed: They were anastomosed in a Y fashion to a ligated anterior descending coronary artery. Electromagnetic flow probes measured graft flow (with the other graft occluded) before and after 15 minutes of drug infusion. The order of drug infusion was randomized and changes were compared by tests for paired differences. Phenylephrine (2 micrograms/kg/min) decreased flow in both the internal mammary and saphenous vein grafts, whereas norepinephrine (0.1 microgram/kg/min) increased flow in both grafts. Epinephrine (0.05 microgram/kg/min) increased mammary artery flow 16% +/- 6% but decreased saphenous vein graft flow 9% +/- 7%. Nitroglycerin (1 microgram/kg/min) significantly increased internal mammary flow (36% +/- 13%), from 47 +/- 7 to 59 +/- 7 ml/min (p less than 0.01), whereas flow decreased significantly in the saphenous vein graft 14% +/- 3%, from 64 +/- 9 to 59 +/- 8 ml/min (p less than 0.01). Nitroprusside (1 microgram/kg/min) decreased mammary artery flow 12% +/- 2%, from 50 +/- 7 to 44 +/- 7 ml/min (p less than 0.01), but increased saphenous vein graft flow 25% +/- 8%, from 64 +/- 9 to 77 +/- 7 ml/min (p less than 0.01). All hemodynamic variables were unchanged, except for norepinephrine, which significantly increased the first derivative of left ventricular pressure. The results suggest that flow through the canine internal mammary artery is changed by the drugs commonly used in perioperative management. Epinephrine and nitroglycerin increased internal mammary artery flow and decreased saphenous vein graft flow, whereas nitroprusside had the opposite effect. The vascular reactivity of the internal mammary artery must be considered when these drugs are used after coronary revascularization.